The Effect of Pentosan Polysulphate (SP54) on the Fibrinolytic Enzyme System - A Human Volunteer and Experimental Animal Study

Summary Pentosan polysulphate causes an increase in plasminogen activator activity in plasma both after oral ingestion and after subcutaneous injection. The effect is greatest after 3 h and has disappeared by 6 h. Repeat doses by mouth over 5 days elicit a similar response. The recorded increase in activity is due largely to the release of tissue-type plasminogen activator (tPA) from the endothelium according to the antigen assay although there could be a small contribution from Factor XH-related “intrinsic” fibrinolysis induced in vitro. SP54 enhances activity ex vivo by a non-specific surface effect, and this phenomenon may contribute the increased levels of activity seen in vitro. Administration of SP54 to animals elicits a similar increase in activator activity, the intramuscular route being slightly more effective. Results with an inferior vena cava thrombosis model in the rat suggest that pentosan polysulphate may induce a thrombolytic effect.

[1]  P. Gaffney,et al.  A Collaborative Study of a Proposed International Standard for Tissue Plasminogen Activator (t-PA) , 1985, Thrombosis and Haemostasis.

[2]  P. Gaffney,et al.  Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis. , 1983, Thrombosis research.

[3]  D. Collen,et al.  Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. , 1983, The Journal of laboratory and clinical medicine.

[4]  P. Gaffney,et al.  Exercise-Induced Fibrinolysis – Fact or Fiction? , 1982, Thrombosis and Haemostasis.

[5]  H. Vinazzer,et al.  Influence of heparin; of different heparin fractions and of a low molecular weight heparin-like substance on the mechanism of fibrinolysis. , 1982, Thrombosis research.

[6]  P. Gaffney,et al.  A Comparison of Pentosan Polysulphate and Heparin II: Effects of Subcutaneous Injection , 1982, Thrombosis and Haemostasis.

[7]  D. Bergqvist,et al.  A comparative study of Dextran 70 and a sulphated polysaccharide in the prevention of postoperative thromboembolic complications , 1981, The British journal of surgery.

[8]  D. Keber,et al.  Influence of Moderate and Strenuous Daily Physical Activity on Fibrinolytic Activity of Blood: Possibility of Plasminogen Activator Stores Depletion , 1979, Thrombosis and Haemostasis.

[9]  C. Kluft.  Studies on the Fibrinolytic System in Human Plasma: Quantitative Determination of Plasminogen Activators and Proactivators , 1979, Thrombosis and Haemostasis.

[10]  T. Astrup,et al.  A plasminogen proactivator-activator system in human blood effective in absence of Hageman Factor. , 1974, Thrombosis research.

[11]  J. Spero,et al.  The Thrombolytic Effect of Heparin and a Heparin-Like Substance, SP 54 , 1967, Thrombosis and Haemostasis.

[12]  C. Doutremépuich,et al.  Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fraction. , 1983, Haemostasis.

[13]  P. Gaffney,et al.  Some observations on the release of extrinsic and intrinsic plasminogen activators during exercise in man. , 1980, Haemostasis.

[14]  B. Lindblad,et al.  Prevention of postoperative thromboembolic complications. A prospective comparison between dextran 70, dihydroergotamine heparin and a sulphated polysaccharide. , 1980, Acta chirurgica Scandinavica.

[15]  N. Marsh.  Measurement of fibrinolytic capacity by the euglobulin lysis time method--a problem of "units". , 1978, Thrombosis research.

[16]  N. Marsh,et al.  Evaluation of the Fibrin Plate Method for Estimating Plasminogen Activators , 1972, Thrombosis and Haemostasis.

[17]  B. Olow.  On fibrinolysis induced by streptokinase in man , 1962 .